Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Optimization of High-Risk Hip Fracture Surgery Patients
2010-022816-38Phase 4Completed
- Sponsor
- Department of Anesthesiology & Intensive Care
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dobutamine and levosimendan in hip fracture, heart failure (HF), left ventricular dysfunction and 1 more, sponsored by Department of Anesthesiology & Intensive Care. Primary endpoint: Major cardiac complications. Started Oct 2010; status: completed.
02
Drugs
dobutaminelevosimendan
03
Conditions
hip fractureheart failure (HF)left ventricular dysfunctionmyocardial infarction (MI)
Beyond the preview
Go deeper on 2010-022816-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022816-38.